Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Astellas seeks marketing approval for Flublok recombinant influenza vaccine in Japan

Protein Sciences Corporation announced today that Astellas Pharma has submitted an application for marketing approval of recombinant influenza HA vaccine ASP7374 (marketed as Flublok® in the United States by Protein Sciences) to the Ministry of Health, Labour and Welfare in Japan for the prevention of influenza.

31 May 2014

MediNatura to purchase Heel Group's USA operation

MediNatura™ Incorporated, a Delaware Corporation headquartered in greater Philadelphia, today announced an agreement to purchase the Heel Group's USA operations, which is expected to be completed in late August 2014.

31 May 2014

Northwestern Medicine allergist offers tips to fight allergies

Nasal congestion, sneezing, and itchy and watery eyes — for the nearly 50 million Americans with seasonal allergies, these are the true rites of spring

31 May 2014

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Inovio Pharmaceuticals, Inc. today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

30 May 2014

Medicare intends to penalize hospitals for giving followup care to seniors

Medicare has announced plans to penalize 2,633 hospitals for giving followup care to seniors, even if the care was appropriate.

30 May 2014

Hand sanitizer powerful weapon against current measles outbreak

With measles cases in the U.S. at a 20-year high, it's more important than ever to keep your hands clean. Measles, caused by an airborne virus that's spread by breathing, coughing, and sneezing, can linger for up to two hours in the air or on surfaces.

30 May 2014

Midwest allergist records highest mold count for the 2014 allergy reporting season

The official allergy count for the Midwest today recorded the highest count for mold in the 2014 allergy recording season.

29 May 2014

Culture-based tests can help in accurate diagnosis of sore throats

Clinical guidelines conflict on testing teens and adults whose symptoms point to a possible strep throat.

29 May 2014

Ebola research: an interview with Professor Easton, University of Warwick

Ebola virus belongs to a group of viruses that have been known for some time. It was first isolated as a result of an infection in a primate, in a monkey colony, in monkeys that were being used for research in the Philippines.

28 May 2014

Contemporary dataset reveals burden of paediatric pneumococcal disease

Children with chronic or immunocompromising medical conditions continue to be at increased risk for developing pneumococcal disease in the current era of universal immunisation, US researchers report.

28 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

InControl Medical’s InToneMV gains FDA clearance for treatment of urinary, fecal incontinence in male

InControl Medical gains FDA clearance for InTone®MV providing the 12 million men nationally who suffer with urinary or fecal incontinence a non-surgical, implant-free solution

28 May 2014

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Inovio Pharmaceuticals, Inc. announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge.

27 May 2014

Employers to implement mandatory influenza vaccination policies for health care workers

Employers planning to implement mandatory influenza vaccination policies for health care workers need to understand the implications, according to an analysis published in CMAJ (Canadian Medical Association Journal).

27 May 2014

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Inovio Pharmaceuticals, Inc. today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock.

23 May 2014

Growing resistance to antibiotics demands a coordinated global response, say experts

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, experts say.

23 May 2014

American Association of Diabetes Educators suggests tips for safe travel

AAA estimates 36.1 million people will travel this Memorial Day weekend. If diabetes is your constant companion, that doesn't mean you can't enjoy traveling, whether traversing America in an RV or flying to the far reaches of the globe. Ensuring you stay healthy and keep your glucose levels on an even keel does require a little bit of organization and planning ahead, though.

23 May 2014

Despite worsening economic conditions, infant health improves among poor Americans

Despite worsening economic conditions for those at the bottom, infant health has steadily improved among the most disadvantaged Americans, according to a review published in Science by Princeton University's Woodrow Wilson School of Public and International Affairs

23 May 2014

New project aims at saving lives of mothers, newborns in developing countries

Grand Challenges Canada, funded by the Government of Canada, today announces investments of $12 million in projects worldwide, aimed squarely at improving the health and saving the lives of mothers, newborns and children in developing countries.

22 May 2014

School-based influenza vaccine programs limited by low rates of reimbursement

School-based influenza vaccine programs have the potential to reach many children at affordable costs and with parental support, but these programs are limited by low rates of reimbursement from third-party payers, according to recently published study results by researchers from the University of Colorado School of Medicine.

21 May 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Astellas seeks marketing approval for Flublok recombinant influenza vaccine in Japan

MediNatura to purchase Heel Group's USA operation

Northwestern Medicine allergist offers tips to fight allergies

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Medicare intends to penalize hospitals for giving followup care to seniors

Hand sanitizer powerful weapon against current measles outbreak

Midwest allergist records highest mold count for the 2014 allergy reporting season

Culture-based tests can help in accurate diagnosis of sore throats

Ebola research: an interview with Professor Easton, University of Warwick

Contemporary dataset reveals burden of paediatric pneumococcal disease

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

InControl Medical’s InToneMV gains FDA clearance for treatment of urinary, fecal incontinence in male

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Employers to implement mandatory influenza vaccination policies for health care workers

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Growing resistance to antibiotics demands a coordinated global response, say experts

American Association of Diabetes Educators suggests tips for safe travel

Despite worsening economic conditions, infant health improves among poor Americans

New project aims at saving lives of mothers, newborns in developing countries

School-based influenza vaccine programs limited by low rates of reimbursement

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in